Viralytics Receives Approval To Increase CAVATAK™ Dosage Levels In Intravenous Cancer Trial
Viralytics Limited (ASX: VLA) has received ethics committee approval to increase the dosage levels of CAVATAK™ in its Phase I intravenous breast cancer, prostate cancer and melanoma trial. Dosing will now commence at what was the highest dosing level of the original trial schedule and escalate to approximately 100 fold higher levels than planned for [...]
Bracelets, Labels With Intelligent Ink Could Warn Of Sunburn Danger
Scientists in the UK have developed UV-sensitive “intelligent inks” that change colour when there is danger of sunburn and can be tuned to suit different skin types, which is something that current UV dosimeters can’t cope with. However, they also said the challenge will not be cost or technology, since the indicators are cheap and [...]
Bed Bugs Seem Tough But Harmless, For Now
A US study that reviewed the available evidence on bed bugs found that while they are highly resistant to various ways of getting rid of them, they seem to be more of a nuisance than a serious health problem, but the possibility that they could one day serve as a vehicle for disease has not [...]
Leading Florida Dermatologist Launches Study To Evaluate ArteFill For Acne Scars
Leading St. Petersburg, FL – based dermatologist, Dr. James Spencer, announced he is conducting a study to evaluate ArteFill, a non-resorbable dermal filler, for the treatment of acne scars, and other depressed atrophic scars. ArteFill is a non-resorbable dermal filler that is currently approved to treat nasolabial folds, or smile line wrinkles. James M. Spencer, [...]
Sunscreens With Benzophenone-3 Unsuitable For Children
Sunscreens that contain benzophenone-3 provide effective protection against both UVA and UVB radiation, but these preparations should not be used for young children. The substance can be found in the urine of adults several days after coming home from a holiday in the sun. A doctoral thesis from the Sahlgrenska Academy has recently presented these [...]
